Atlanta’s Biotech Scene Prepares for New Heights

Source: BioSpace A new project has capped off construction in Midtown Atlanta, providing physical real estate that experts say is sorely needed for the region’s growing biotech ecosystem, now home to more than 4,000 life science companies. KEEP READING AT BIOSPACE HERE.

Read More

AdvaMed Statement on the Release of FDA Rule on Laboratory-Developed Tests

WASHINGTON, D.C. – Today, AdvaMed, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA’s final rule for Laboratory Developed Tests (LDTs): “We appreciate FDA’s commitment to ensuring the safety and effectiveness of in vitro diagnostic tests, regardless of their source, which is what today’s rule…

Read More

A Letter from GCMI Interim Executive Director Saylan Lukas – GCMI’s Continuing Commitment to Excellence in Medtech Innovation

Medtech and life science innovation is rigorous. It requires high levels of acumen and proficiency in multiple disciplines. It can also be immensely capital intensive. Tiffany Wilson founded Atlanta’s Global Center for Medical Innovation (GCMI) in 2012 to help medtech innovators de-risk their technologies, increasing their odds of successful commercialization and positive patient outcomes within…

Read More

Connecting the Dots: Athens Career Academy Unveils Biotech Track, Shaping Real Futures for High School Students

FOR IMMEDIATE RELEASE–February 22, 2024– Athens, Georgia – The Athens Community Career Academy, part of the Clarke County School District, is ushering in a new era of education and community development with its innovative Biotechnology Track. Designed to meet the changing needs of the workforce in Athens, this program aims to prepare high school students…

Read More

Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication

January 16, 2024 08:00 ET| Source: Aruna Bio BOSTON and ATHENS, Ga., Jan. 16, 2024 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a pioneer in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of lead program,…

Read More

Celebrating Evolution and Innovation: Our look back at 2023 and ahead to 2024

The life science industry and its innovations are always advancing, always evolving in a never ending quest to address unmet patient and clinical needs. Industry organizations like Georgia Bio may not experience the frequency of flux – driven in large part by new technologies – as the members and partner entities we serve, but when…

Read More

Large Majority of Americans Say Consideration of Clinical Trial Participation Should be a Part of Regular Health Care

New National Public Opinion Survey Reveals Willingness to Participate in Clinical Trials; Importance of Trials Reflecting the Population; Concerns About Sharing Personal Health Information Have Grown   Arlington, VA – December 5, 2023 – According to survey findings released today, an overwhelming majority of Americans (87%) agree that health care professionals should discuss clinical trials…

Read More

Echoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast

In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…

Read More